Cyteir Therapeutics files certificate of dissolution; estimates $3.10-$3.16 per share liquidation distribution

Cyteir Therapeutics, Inc.

Filed Certificate of Dissolution with Delaware Secretary of State on March 20, 2024, dissolving the company.
Record date set as March 20, 2024 for liquidation distributions; stock transfer books closed immediately.
Estimated aggregate cash distribution between $3.10 and $3.16 per share, with first payment expected in Q2 2024.
Terminated Amended and Restated 2012 Stock Incentive Plan, 2021 Equity Incentive Plan, and Employee Stock Purchase Plan.

item 1.02 item 3.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Cyteir Therapeutics, Inc. terminated Amended and Restated 2012 Stock Incentive Plan valued at terminated.

Action: termination
Agreement: equity purchase
Value: terminated

Exact text from the filing

Item 1.02 Termination of Material Definitive Agreement Immediately following the filing of the Certificate of Dissolution (as defined below) with the Secretary of State of the State of Delaware, Cyteir Therapeutics, Inc. (the “Company”) terminated the Company’s Amended and Restated 2012 Stock Incentive Plan, the Company’s 2021 Equity Incentive Plan and the Company’s 2021 Employee Stock Purchase Plan.

View on SEC.gov

547 material agreements filed in the last 30 days. Browse all material agreements →

Source: SEC EDGAR

accession 0000950170-24-034247

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.